1. Heaton, R.K., D.B. Clifford, D.R. Franklin, Jr., S.P. Woods, C. Ake, F. Vaida, R.J. Ellis, S.L. Letendre, T.D. Marcotte, J.H. Atkinson, M. Rivera-Mindt, O.R. Vigil, M.J. Taylor, A.C. Collier, C.M. Marra, B.B. Gelman, J.C. McArthur, S. Morgello, D.M. Simpson, J.A. McCutchan, I. Abramson, A. Gamst, C. Fennema-Notestine, T.L. Jernigan, J. Wong, I. Grant, and C. Group, HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 2010. 75(23): p. 2087-96.
2. The Prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-Infected Adults: A Systematic Review and Meta-Analysis;Wei J;Frontiers in Neurology,2020
3. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection;Janssen RS;Neurology,1991
4. Updated research nosology for HIV-associated neurocognitive disorders;Antinori A;Neurology,2007
5. Cerebrospinal fluid (CSF) CD8 + T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND);Schrier RD;PLoS One,2015